Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Polycystic Ovary Syndrome 1 Non-alcoholic Fatty Liver Disease 1 Multiple Myeloma 1 Growth Hormone-Secreting Pituitary Adenoma 1 Glioblastoma 1 Fatty Liver 1 Drug Resistant Epilepsy 1 Breast Neoplasms 1 Brain Neoplasms 1 Autism Spectrum Disorder 1 Adenocarcinoma of Lung 1

Interventions

Capecitabine 29 Oxaliplatin 28 Fluorouracil 16 Radiotherapy 15 Drug Therapy 11 Leucovorin 10 Bevacizumab 10 Surgical Procedures, Operative 9 Chemoradiotherapy 8 Radiation 7 sintilimab 6 Consolidation Chemotherapy 6 tislelizumab 5 spartalizumab 5 Specimen Handling 5 Irinotecan 5 Folfox protocol 5 trifluridine tipiracil drug combination 4 XELOX 4 Neoadjuvant Therapy 4 Endoscopy 4 Cetuximab 4 Biopsy 4 toripalimab 3 pembrolizumab 3 irinotecan sucrosofate 3 X-Rays 3 Radiotherapy, Intensity-Modulated 3 Proctectomy 3 Mastectomy, Segmental 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Rectal Neoplasms × Diet, Ketogenic × Clear all

NCT05938322 2025-09-05

KOMPARC

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡